Reconstructing Oral Cavity Tumor Evolution Through Brush Biopsy

Overview

Journal Sci Rep

Specialty Science

Date 2024 Sep 29

PMID 39343812

Authors

Evit John

Tom Lesluyes

Toby M Baker

Maxime Tarabichi

Ann Gillenwater

Jennifer R Wang

Peter Van Loo

Xiao Zhao

Affiliations

Soon will be listed here.

Abstract

Oral potentially malignant disorders (OPMDs) with genomic alterations have a heightened risk of evolving into oral squamous cell carcinoma (OSCC). Currently, genomic data are typically obtained through invasive tissue biopsy. However, brush biopsy is a non-invasive method that has been utilized for identifying dysplastic cells in OPMD but its effectiveness in reflecting the genomic landscape of OPMDs remains uncertain. This pilot study investigates the potential of brush biopsy samples in accurately reconstructing the genomic profile and tumor evolution in a patient with both OPMD and OSCC. We analyzed single nucleotide variants (SNVs), copy number aberrations (CNAs), and subclonal architectures in paired tissue and brush biopsy samples. The results showed that brush biopsy effectively captured 90% of SNVs and had similar CNA profiles as those seen in its paired tissue biopsies in all lesions. It was specific, as normal buccal mucosa did not share these genomic alterations. Interestingly, brush biopsy revealed shared SNVs and CNAs between the distinct OPMD and OSCC lesions from the same patient, indicating a common ancestral origin. Subclonal reconstruction confirmed this shared ancestry, followed by divergent evolution of the lesions. These findings highlight the potential of brush biopsies in accurately representing the genomic profile of OPL and OSCC, proving insight into reconstructing tumor evolution.

References

Conway D, Purkayastha M, Chestnutt I . The changing epidemiology of oral cancer: definitions, trends, and risk factors. Br Dent J. 2018; 225(9):867-873. DOI: 10.1038/sj.bdj.2018.922. View

Miller C, Mohandas T, Wolf D, Prokocimer M, Rotter V, Koeffler H . Human p53 gene localized to short arm of chromosome 17. Nature. 1986; 319(6056):783-4. DOI: 10.1038/319783a0. View

Farah C, Jessri M, Bennett N, Dalley A, Shearston K, Fox S . Exome sequencing of oral leukoplakia and oral squamous cell carcinoma implicates DNA damage repair gene defects in malignant transformation. Oral Oncol. 2019; 96:42-50. DOI: 10.1016/j.oraloncology.2019.07.005. View

Wang J, Li B, Luo M, Huang J, Zhang K, Zheng S . Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance. Signal Transduct Target Ther. 2024; 9(1):83. PMC: 10991592. DOI: 10.1038/s41392-024-01779-3. View

Errazquin R, Carrasco E, Del Marro S, Sunol A, Peral J, Ortiz J . Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma. Cancers (Basel). 2023; 15(6). PMC: 10046988. DOI: 10.3390/cancers15061871. View

Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S . Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res. 1996; 56(11):2488-92. View

Bolli N, Avet-Loiseau H, Wedge D, Van Loo P, Alexandrov L, Martincorena I . Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014; 5:2997. PMC: 3905727. DOI: 10.1038/ncomms3997. View

MCBRIDE O, Merry D, Givol D . The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proc Natl Acad Sci U S A. 1986; 83(1):130-4. PMC: 322805. DOI: 10.1073/pnas.83.1.130. View

Taniguchi N, Kizuka Y . Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv Cancer Res. 2015; 126:11-51. DOI: 10.1016/bs.acr.2014.11.001. View

10.

Li H, Durbin R . Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25(14):1754-60. PMC: 2705234. DOI: 10.1093/bioinformatics/btp324. View

11.

Armaghany T, Wilson J, Chu Q, Mills G . Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012; 5(1):19-27. PMC: 3348713. View

12.

Wu C, Roz L, Sloan P, Read A, Holland S, Porter S . Deletion mapping defines three discrete areas of allelic imbalance on chromosome arm 8p in oral and oropharyngeal squamous cell carcinomas. Genes Chromosomes Cancer. 1997; 20(4):347-53. DOI: 10.1002/(sici)1098-2264(199712)20:4<347::aid-gcc5>3.0.co;2-1. View

13.

Van Loo P, Nordgard S, Lingjaerde O, Russnes H, Rye I, Sun W . Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A. 2010; 107(39):16910-5. PMC: 2947907. DOI: 10.1073/pnas.1009843107. View

14.

Yoo W, Cho S, Lee Y, Park G, Kim M, Kim B . Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx. J Korean Med Sci. 2004; 19(3):345-51. PMC: 2816833. DOI: 10.3346/jkms.2004.19.3.345. View

15.

Cibulskis K, Lawrence M, Carter S, Sivachenko A, Jaffe D, Sougnez C . Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013; 31(3):213-9. PMC: 3833702. DOI: 10.1038/nbt.2514. View

16.

Kim S, Han Y, Song J, Lee C, Kang K, Yi J . Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC). Clin Epigenetics. 2019; 11(1):116. PMC: 6689875. DOI: 10.1186/s13148-019-0715-0. View

17.

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A . The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303. PMC: 2928508. DOI: 10.1101/gr.107524.110. View

18.

Haruki S, Imoto I, Kozaki K, Matsui T, Kawachi H, Komatsu S . Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma. Carcinogenesis. 2010; 31(6):1027-36. DOI: 10.1093/carcin/bgq053. View

19.

Zhou X, Temam S, Chen Z, Ye H, Mao L, Wong D . Allelic imbalance analysis of oral tongue squamous cell carcinoma by high-density single nucleotide polymorphism arrays using whole-genome amplified DNA. Hum Genet. 2005; 118(3-4):504-7. DOI: 10.1007/s00439-005-0069-x. View

20.

Nakagawa T, Pimkhaokham A, Suzuki E, Omura K, Inazawa J, Imoto I . Genetic or epigenetic silencing of low density lipoprotein receptor-related protein 1B expression in oral squamous cell carcinoma. Cancer Sci. 2006; 97(10):1070-4. PMC: 11159176. DOI: 10.1111/j.1349-7006.2006.00283.x. View